Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2014 | -3.07 Million USD | -359.29% |
| 2013 | -83.33 Thousand USD | 61.61% |
| 2012 | -293.07 Thousand USD | -2407.51% |
| 2011 | 88.04 Thousand USD | 102.84% |
| 2010 | -3.06 Million USD | -22.06% |
| 2009 | -5.98 Million USD | -294.72% |
| 2008 | 87.07 Thousand USD | 120.29% |
| 2007 | -1.95 Million USD | 6.38% |
| 2006 | -5.71 Million USD | -490.2% |
| 2005 | -1.16 Million USD | 33.66% |
| 2004 | -2.16 Million USD | 95.49% |
| 2003 | -38.89 Million USD | -1609.25% |
| 2002 | -2.27 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2015 Q3 | -3.32 Million USD | -2348.86% |
| 2015 Q1 | -872.11 Thousand USD | 65.06% |
| 2015 Q2 | -135.93 Thousand USD | 84.41% |
| 2014 Q1 | -316.12 Thousand USD | 68.13% |
| 2014 FY | - USD | -359.29% |
| 2014 Q4 | -2.49 Million USD | -582.4% |
| 2014 Q3 | -365.76 Thousand USD | 9.52% |
| 2014 Q2 | -404.23 Thousand USD | -27.87% |
| 2013 FY | - USD | 61.61% |
| 2013 Q4 | -992 Thousand USD | -4488.43% |
| 2013 Q1 | 206.66 Thousand USD | -77.73% |
| 2013 Q3 | 22.6 Thousand USD | 200.41% |
| 2013 Q2 | -22.51 Thousand USD | -110.89% |
| 2012 Q4 | 927.91 Thousand USD | 11219.45% |
| 2012 Q1 | -153.07 Thousand USD | -184.7% |
| 2012 FY | - USD | -2407.51% |
| 2012 Q3 | -8345.00 USD | 85.99% |
| 2012 Q2 | -59.57 Thousand USD | 61.08% |
| 2011 Q4 | 180.73 Thousand USD | 461.42% |
| 2011 FY | - USD | 102.84% |
| 2011 Q2 | -75.88 Thousand USD | -302.24% |
| 2011 Q3 | -50 Thousand USD | 34.1% |
| 2011 Q1 | 37.52 Thousand USD | 102.65% |
| 2010 Q1 | -411.53 Thousand USD | 91.83% |
| 2010 FY | - USD | -22.06% |
| 2010 Q4 | -1.41 Million USD | -20611.74% |
| 2010 Q3 | 6908.00 USD | 100.68% |
| 2010 Q2 | -1.01 Million USD | -146.29% |
| 2009 FY | - USD | -294.72% |
| 2009 Q2 | -15.24 Million USD | -175.82% |
| 2009 Q4 | -5.03 Million USD | -112.62% |
| 2009 Q3 | -2.37 Million USD | 84.46% |
| 2009 Q1 | 20.11 Million USD | 1389.19% |
| 2008 Q3 | -169.53 Thousand USD | -144.86% |
| 2008 FY | - USD | 120.29% |
| 2008 Q4 | 1.35 Million USD | 896.56% |
| 2008 Q1 | -290.78 Thousand USD | 95.8% |
| 2008 Q2 | 377.95 Thousand USD | 229.98% |
| 2007 Q1 | -461 Thousand USD | 85.84% |
| 2007 FY | - USD | 6.38% |
| 2007 Q4 | -6.91 Million USD | -3039.15% |
| 2007 Q3 | -220.32 Thousand USD | -34.56% |
| 2007 Q2 | -163.73 Thousand USD | 64.48% |
| 2006 Q2 | -623.6 Thousand USD | -30.88% |
| 2006 Q3 | -348.98 Thousand USD | 44.04% |
| 2006 FY | - USD | -490.2% |
| 2006 Q4 | -3.25 Million USD | -832.63% |
| 2006 Q1 | -476.45 Thousand USD | -162.89% |
| 2005 Q1 | -831.29 Thousand USD | 11.21% |
| 2005 Q4 | 757.64 Thousand USD | 317.24% |
| 2005 Q3 | -348.75 Thousand USD | -80.21% |
| 2005 FY | - USD | 33.66% |
| 2005 Q2 | -193.52 Thousand USD | 76.72% |
| 2004 Q1 | -208.31 Thousand USD | 99.42% |
| 2004 Q4 | -936.2 Thousand USD | -257.84% |
| 2004 FY | - USD | 95.49% |
| 2004 Q3 | -261.62 Thousand USD | 24.57% |
| 2004 Q2 | -346.84 Thousand USD | -66.5% |
| 2003 Q1 | -1.04 Million USD | -270.37% |
| 2003 Q4 | -36.14 Million USD | -3845.21% |
| 2003 Q3 | -916.06 Thousand USD | -15.46% |
| 2003 FY | - USD | -1609.25% |
| 2003 Q2 | -793.04 Thousand USD | 23.77% |
| 2002 Q4 | -280.26 Thousand USD | 85.13% |
| 2002 Q1 | -246.92 Thousand USD | 0.0% |
| 2002 Q3 | -1.88 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -164.617% |
| Atlantic International Corp. | -5.38 Million USD | 42.899% |
| Biocept, Inc. | -30.24 Million USD | 89.823% |
| Bioqual, Inc. | 3.03 Million USD | 201.492% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -306.337% |
| DermTech, Inc. | -97.89 Million USD | 96.856% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.106% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 84.797% |
| iMD Companies, Inc. | -154.65 Thousand USD | -1889.858% |
| IDenta Corp. | 71.58 Thousand USD | 4398.958% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 180.206% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 8054.239% |
| InVitro International | 6680.00 USD | 46170.284% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 43.387% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -25262.576% |
| Medical Imaging Corp. | -896.74 Thousand USD | -243.186% |
| NovelStem International Corp. | -3.78 Million USD | 18.709% |
| Optigenex Inc. | -1.18 Million USD | -159.327% |
| PharmChem, Inc. | 1.05 Million USD | 392.035% |
| Proteome Sciences plc | -1.13 Million USD | -170.668% |
| Response Genetics, Inc | -19.66 Million USD | 84.351% |
| Rennova Health, Inc. | -234.81 Thousand USD | -1210.604% |
| RushNet, Inc. | -614.85 Thousand USD | -400.526% |
| ScreenPro Security Inc. | -3.43 Million USD | 10.405% |
| Stella Diagnostics Inc. | -5.7 Million USD | 46.079% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 70.035% |
| Todos Medical Ltd. | -9.39 Million USD | 67.24% |